210 related articles for article (PubMed ID: 32776461)
1. Polyanhydride nanoparticles stabilize pancreatic cancer antigen MUC4β.
Liu L; Kshirsagar P; Christiansen J; Gautam SK; Aithal A; Gulati M; Kumar S; Solheim JC; Batra SK; Jain M; Wannemuehler MJ; Narasimhan B
J Biomed Mater Res A; 2021 Jun; 109(6):893-902. PubMed ID: 32776461
[TBL] [Abstract][Full Text] [Related]
2. Amphiphilic polyanhydride-based recombinant MUC4β-nanovaccine activates dendritic cells.
Banerjee K; Gautam SK; Kshirsagar P; Ross KA; Spagnol G; Sorgen P; Wannemuehler MJ; Narasimhan B; Solheim JC; Kumar S; Batra SK; Jain M
Genes Cancer; 2019 May; 10(3-4):52-62. PubMed ID: 31258832
[TBL] [Abstract][Full Text] [Related]
3. The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response.
Wafa EI; Geary SM; Goodman JT; Narasimhan B; Salem AK
Acta Biomater; 2017 Mar; 50():417-427. PubMed ID: 28063991
[TBL] [Abstract][Full Text] [Related]
4. Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen.
Petersen LK; Phanse Y; Ramer-Tait AE; Wannemuehler MJ; Narasimhan B
Mol Pharm; 2012 Apr; 9(4):874-82. PubMed ID: 22380593
[TBL] [Abstract][Full Text] [Related]
5. MUCIN-4 (MUC4) is a novel tumor antigen in pancreatic cancer immunotherapy.
Gautam SK; Kumar S; Dam V; Ghersi D; Jain M; Batra SK
Semin Immunol; 2020 Feb; 47():101391. PubMed ID: 31952903
[TBL] [Abstract][Full Text] [Related]
6. Polyanhydride Nanovaccines Induce Germinal Center B Cell Formation and Sustained Serum Antibody Responses.
Vela Ramirez JE; Tygrett LT; Hao J; Habte HH; Cho MW; Greenspan NS; Waldschmidt TJ; Narasimhan B
J Biomed Nanotechnol; 2016 Jun; 12(6):1303-11. PubMed ID: 27319223
[TBL] [Abstract][Full Text] [Related]
7. Structural and antigenic stability of H5N1 hemagglutinin trimer upon release from polyanhydride nanoparticles.
Ross KA; Loyd H; Wu W; Huntimer L; Wannemuehler MJ; Carpenter S; Narasimhan B
J Biomed Mater Res A; 2014 Nov; 102(11):4161-8. PubMed ID: 24443139
[TBL] [Abstract][Full Text] [Related]
8. Retention of structure, antigenicity, and biological function of pneumococcal surface protein A (PspA) released from polyanhydride nanoparticles.
Haughney SL; Petersen LK; Schoofs AD; Ramer-Tait AE; King JD; Briles DE; Wannemuehler MJ; Narasimhan B
Acta Biomater; 2013 Sep; 9(9):8262-71. PubMed ID: 23774257
[TBL] [Abstract][Full Text] [Related]
9. Characterizing the antitumor response in mice treated with antigen-loaded polyanhydride microparticles.
Joshi VB; Geary SM; Carrillo-Conde BR; Narasimhan B; Salem AK
Acta Biomater; 2013 Mar; 9(3):5583-9. PubMed ID: 23153760
[TBL] [Abstract][Full Text] [Related]
10. Cellular Internalization Mechanisms of Polyanhydride Particles: Implications for Rational Design of Drug Delivery Vehicles.
Phanse Y; Lueth P; Ramer-Tait AE; Carrillo-Conde BR; Wannemuehler MJ; Narasihan B; Bellaire BH
J Biomed Nanotechnol; 2016 Jul; 12(7):1544-52. PubMed ID: 29337493
[TBL] [Abstract][Full Text] [Related]
11. Harvesting murine alveolar macrophages and evaluating cellular activation induced by polyanhydride nanoparticles.
Chavez-Santoscoy AV; Huntimer LM; Ramer-Tait AE; Wannemuehler M; Narasimhan B
J Vis Exp; 2012 Jun; (64):e3883. PubMed ID: 22710245
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and Characterization of Rapidly Degrading Polyanhydrides as Vaccine Adjuvants.
Kelly SM; Mitra A; Mathur S; Narasimhan B
ACS Biomater Sci Eng; 2020 Jan; 6(1):265-276. PubMed ID: 33463223
[TBL] [Abstract][Full Text] [Related]
13. Amphiphilic polyanhydrides for protein stabilization and release.
Torres MP; Determan AS; Anderson GL; Mallapragada SK; Narasimhan B
Biomaterials; 2007 Jan; 28(1):108-16. PubMed ID: 16965812
[TBL] [Abstract][Full Text] [Related]
14. High-throughput analysis of protein stability in polyanhydride nanoparticles.
Petersen LK; Sackett CK; Narasimhan B
Acta Biomater; 2010 Oct; 6(10):3873-81. PubMed ID: 20388561
[TBL] [Abstract][Full Text] [Related]
15. Encapsulation into amphiphilic polyanhydride microparticles stabilizes Yersinia pestis antigens.
Carrillo-Conde B; Schiltz E; Yu J; Chris Minion F; Phillips GJ; Wannemuehler MJ; Narasimhan B
Acta Biomater; 2010 Aug; 6(8):3110-9. PubMed ID: 20123135
[TBL] [Abstract][Full Text] [Related]
16. High-Throughput Synthesis and Screening of Rapidly Degrading Polyanhydride Nanoparticles.
Mullis AS; Jacobson SJ; Narasimhan B
ACS Comb Sci; 2020 Apr; 22(4):172-183. PubMed ID: 32125826
[TBL] [Abstract][Full Text] [Related]
17. Effect of polymer chemistry and fabrication method on protein release and stability from polyanhydride microspheres.
Lopac SK; Torres MP; Wilson-Welder JH; Wannemuehler MJ; Narasimhan B
J Biomed Mater Res B Appl Biomater; 2009 Nov; 91(2):938-947. PubMed ID: 19642209
[TBL] [Abstract][Full Text] [Related]
18. Polyanhydride nanovaccine against swine influenza virus in pigs.
Dhakal S; Goodman J; Bondra K; Lakshmanappa YS; Hiremath J; Shyu DL; Ouyang K; Kang KI; Krakowka S; Wannemuehler MJ; Won Lee C; Narasimhan B; Renukaradhya GJ
Vaccine; 2017 Feb; 35(8):1124-1131. PubMed ID: 28117173
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies recognizing the non-tandem repeat regions of the human mucin MUC4 in pancreatic cancer.
Jain M; Venkatraman G; Moniaux N; Kaur S; Kumar S; Chakraborty S; Varshney GC; Batra SK
PLoS One; 2011; 6(8):e23344. PubMed ID: 21886786
[TBL] [Abstract][Full Text] [Related]
20. Lipocalin-2-loaded amphiphilic polyanhydride microparticles accelerate cell migration.
Petersen LK; Determan AS; Westgate C; Bendickson L; Nilsen-Hamilton M; Narasimhan B
J Biomater Sci Polym Ed; 2011; 22(9):1237-52. PubMed ID: 20615357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
